Parus Finance (Uk) LTD Merck & Co., Inc. Transaction History

Parus Finance (Uk) LTD

$310 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $36,200 - $46,413	-414 Reduced 15.63%	2,234 $247,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $2.03 Million - $2.28 Million	-23,964 Reduced 90.05%	2,648 $228,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $4.87 Million - $5.52 Million	-58,372 Reduced 68.69%	26,612 $2.43 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $2.09 Million - $2.34 Million	-28,456 Reduced 25.08%	84,984 $6.97 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $1.94 Million - $2.42 Million	-26,782 Reduced 19.1%	113,440 $8.69 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.57 Million - $1.72 Million	-21,841 Reduced 13.48%	140,222 $10.5 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $91,684 - $101,412	1,304 Added 0.81%	162,063 $12.6 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $401,384 - $472,790	5,829 Added 3.76%	160,759 $12.4 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $962,435 - $1.07 Million	-13,410 Reduced 7.97%	154,930 $12.7 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $387,854 - $439,635	-5,300 Reduced 3.05%	168,340 $14 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $3.68 Million - $4.18 Million	52,200 Added 42.98%	173,640 $13.4 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $702,028 - $973,045	-11,080 Reduced 8.36%	121,440 $9.34 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $1.34 Million - $1.52 Million	-17,320 Reduced 11.56%	132,520 $12.1 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $590,380 - $643,536	7,760 Added 5.46%	149,840 $12.6 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $646,718 - $755,523	-9,260 Reduced 6.12%	142,080 $11.9 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $1.58 Million - $1.8 Million	-22,720 Reduced 13.05%	151,340 $12.6 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $1.35 Million - $1.57 Million	20,760 Added 13.54%	174,060 $13.3 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $8.84 Million - $10.4 Million	153,300 New	153,300 $10.9 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.9 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.7 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.9 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.57 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.91 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parus Finance (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parus Finance (Uk) LTD with notifications on news.

Account